Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease 2024-07-06
  2. Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease 2021-05-13
  3. Clinical application of the experimental ADL test for patients with cognitive impairment: pilot study 2021-01-11

Studies

7 studies carry this tag.

Date range

2004 to 2024

Top journals

  • Scientific reports 2
  • Ageing research reviews 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1
  • Neuroradiology 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Alzheimer's research & therapy 2024-07-06 Biomarkers

    Potential DMT candidates at Butler MAP (n = 50), primarily diagnosed with mild cognitive impairment (n = 29 [58%]) or mild dementia (21 [42%]), were predominantly Aβ-positive (38 [76%]), and half (25 [50%]) were subsequently treated with aducanumab.

  2. Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-05-13 Brain scans and imaging

    The recent development of several tau positron emission tomography (PET) tracers represents a major milestone for the Alzheimer's disease (AD) field.

  3. Clinical application of the experimental ADL test for patients with cognitive impairment: pilot study

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Scientific reports 2021-01-11 Cognitive tests and assessment

    We employed a hospital-based Internet of Things (IoT) platform to validate the role of real-time activities of daily living (ADL) measurement as a digital biomarker for cognitive impairment in a hospital setting.

  4. Cholinergic nervous system and glaucoma: From basic science to clinical applications

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Progress in retinal and eye research 2019-06-23 Brain scans and imaging

    The cholinergic system has a crucial role to play in visual function.

  5. Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Scientific reports 2017-04-18 Brain scans and imaging

    Atrophy patterns on MRI can reliably predict three neuropathological subtypes of Alzheimer's disease (AD): typical, limbic-predominant, or hippocampal-sparing.

  6. Advances in the development of tau PET radiotracers and their clinical applications

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Ageing research reviews 2016-01-21 Brain scans and imaging

    Alzheimer's disease and other neurodegenerative dementias belong to the family of tauopathies.

  7. Diffusion tensor imaging of the brain: review of clinical applications

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroradiology 2004-04-21 Brain scans and imaging

    We review the theoretical background to diffusion tensor imaging (DTI) and some of its commoner clinical applications, such as cerebral ischemia, brain maturation and traumatic brain injury.

All topic tags with their study counts